More stories

  • in

    Trump Administration Has Begun a War on Science, Researchers Say

    Nearly 2,000 scientists urged that Congress restore funding to federal agencies decimated by recent cuts.Some 1,900 leading researchers accused the Trump administration in an open letter on Monday of conducting a “wholesale assault on U.S. science” that could set back research by decades and that threatens the health and safety of Americans.The letter’s signatories, all of them elected members of the National Academies of Sciences, Engineering and Medicine, warned of the damage being done by layoffs at health and science agencies and cuts and delays to funding that has historically supported research inside the government and across American universities.“For over 80 years, wise investments by the U.S. government have built up the nation’s research enterprise, making it the envy of the world,” the letter said. “Astoundingly, the Trump administration is destabilizing this enterprise by gutting funding for research, firing thousands of scientists, removing public access to scientific data and pressuring researchers to alter or abandon their work on ideological grounds.”Read the LetterResearchers at academic institutions nationwide say that U.S. science is being dismantled.Read Document 75 pagesThe letter said that many universities and research institutions had so far “kept silent to avoid antagonizing the administration and jeopardizing their funding.” But, it said, “the nation’s scientific enterprise is being decimated.”The signatories called on Americans to appeal to Congress to protect scientific funding.With Elon Musk’s efforts to cut spending and President Trump’s crackdown on institutions he sees as ideological enemies, the administration has sought to dismantle parts of the federal government’s scientific funding apparatus.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    European universities offer ‘scientific asylum’ to US researchers fleeing Trump’s cuts

    Laced with terms such as “censorship” and “political interference”, the Belgium-based jobs advert was far from typical. The promise of academic freedom, however, hinted at who it was aimed at: researchers in the US looking to flee the funding freezes, cuts and ideological impositions ushered in by Donald Trump’s administration.“We see it as our duty to come to the aid of our American colleagues,” said Jan Danckaert, the rector of Vrije Universiteit Brussel (VUB), in explaining why his university – founded in 1834 to safeguard academia from the interference of church or state – had decided to open 12 postdoctoral positions for international researchers, with a particular focus on Americans.“American universities and their researchers are the biggest victims of this political and ideological interference,” Danckaert said in a statement. “They’re seeing millions in research funding disappear for ideological reasons.”The university is among a handful of institutions across Europe that have begun actively recruiting US researchers, offering themselves as a haven for those keen to escape the Trump administration’s crackdown on research and academia.Since Trump took power in late January, researchers in the US have faced a multipronged attack. Efforts to slash government spending have left thousands of employees bracing for layoffs, including at institutions such as Nasa, the Centers for Disease Control and Prevention, and at the National Oceanic and Atmospheric Administration, the US’s pre-eminent climate research agency. The government’s targeting of “wokeism” has meanwhile sought to root out funding for research deemed to involve diversity, certain kinds of vaccines and any mention of the climate crisis.In France, the director of the prestigious Pasteur Institute in Paris, Yasmine Belkaid, said it was already working to recruit people from across the Atlantic for work in fields such as infectious diseases or the origins of disease.View image in fullscreen“I receive daily requests from people who want to return: French, European or even Americans who no longer feel able to do their research or are afraid to do it freely,” Belkaid told the French newspaper La Tribune. “You might call it a sad opportunity, but it is an opportunity, all the same.”The sentiment was echoed by France’s minister for higher education and research, Philippe Baptiste, in a recent letter that called on research institutions to send in proposals on how best to attract talent from the US. “Many well-known researchers are already questioning their future in the US,” he said. “Naturally, we wish to welcome a certain number of them.”On Thursday, the Netherlands said it was aiming to swiftly launch a fund to attract researchers to the country.While the fund would be open to people of all nationalities, the country’s education minister, Eppo Bruins, hinted at the tensions that have gripped US academia in announcing the plans.“There is currently a great global demand for international top scientific talent. At the same time, the geopolitical climate is changing, which is increasing the international mobility of scientists,” Bruins said in a letter to parliament.“Several European countries are responding to this with efforts to attract international talent,” he added. “I want the Netherlands to remain at the vanguard of these efforts.”The Dutch effort comes after France’s Aix-Marseille University said it had set up a programme – titled Safe Place for Science – that would put aside funding for more than two dozen researchers from the US for three years.skip past newsletter promotionafter newsletter promotion“We wish we didn’t have to do this,” said Éric Berton, the university’s president. “We’re not looking to attract researchers. But we were quite indignant about what was happening and we felt that our colleagues in the US were going through a catastrophe … we wanted to offer some sort of scientific asylum to those whose research is being hindered.”Two weeks after the programme was launched there have been about 100 applications, with researchers from Yale, Nasa and Stanford among those who have expressed interest. The university continues to receive about 10 applications a day, said Berton, many of them from researchers involved in studying climate, health or social sciences.Berton said he hoped universities across Europe would join his in providing a safe space for researchers. “I think that we need to realise the historic moment we’re living through and the serious, long-term consequences this could have,” he said. “Europe must rise to the occasion.”At VUB, the opening of the 12 postdoctoral positions was also aimed at acknowledging the global impact of Trump’s crackdown. Two research projects in which the university was involved – one delving into youth and disinformation and another investigating the transatlantic dialogue between the US and Europe – had been cancelled due to “changed policy priorities”, it said.For the university in Brussels, the openings were also a vindication of sorts. In a 2016 interview with Fox News, Trump had sought to characterise life in Brussels as akin to “living in a hellhole”, falsely accusing migrants in the city of failing to assimilate.“At the time, the statement elicited many emotional reactions in Europe,” the university said. “This gives additional symbolic meaning to the VUB initiative.” More

  • in

    Blue Ghost’s Long Day on the Moon

    <!–> –><!–> [–><!–> –><!–> [–><!–> –><!–> [–><!–> –><!–> –> <!–> –><!–> –><!–> –>Landing<!–> –><!–> [–><!–> –><!–> [–><!–> –><!–> –> <!–> –><!–> –><!–> [–><!–>Several companies and countries have aimed to land on the moon in recent years. The map below shows the crewed Apollo moon landing sites, as well as more recent robotic landings from China, […] More

  • in

    Trump Administration Aims to Eliminate E.P.A.’s Scientific Research Arm

    The Environmental Protection Agency plans to eliminate its scientific research arm, firing as many as 1,155 chemists, biologists, toxicologists and other scientists, according to documents reviewed by Democrats on the House Committee on Science, Space and Technology.The strategy is part of large-scale layoffs, known as a “reduction in force,” being planned by the Trump administration, which is intent on shrinking the federal work force. Lee Zeldin, the administrator of the E.P.A., has said he wants to eliminate 65 percent of the agency’s budget. That would be a drastic reduction — one that experts said could hamper clean water and wastewater improvements, air quality monitoring, the cleanup of toxic industrial sites, and other parts of the agency’s mission.The E.P.A.’s plan, which was presented to White House officials on Friday for review, calls for dissolving the agency’s largest department, the Office of Research and Development, and purging up to 75 percent of the people who work there.The remaining staff members would be placed elsewhere within the E.P.A. “to provide increased oversight and align with administration priorities,” according to the language shared with The New York Times by staff members who work for Democrats on the House science committee.Molly Vaseliou, a spokeswoman for the E.P.A., said in a statement that the agency “is taking exciting steps as we enter the next phase of organizational improvements” and stressed that changes had not been finalized.“We are committed to enhancing our ability to deliver clean air, water and land for all Americans,” she said, adding, “While no decisions have been made yet, we are actively listening to employees at all levels to gather ideas on how to increase efficiency and ensure the E.P.A. is as up to date and effective as ever.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    We Were Badly Misled About Covid

    Since scientists first began playing around with dangerous pathogens in laboratories, the world has experienced four or five pandemics, depending on how you count. One of them, the 1977 Russian flu, was almost certainly sparked by a research mishap. Some Western scientists quickly suspected the odd virus had resided in a lab freezer for a couple of decades, but they kept mostly quiet for fear of ruffling feathers.Yet in 2020, when people started speculating that a laboratory accident might have been the spark that started the Covid-19 pandemic, they were treated like kooks and cranks. Many public health officials and prominent scientists dismissed the idea as a conspiracy theory, insisting that the virus had emerged from animals in a seafood market in Wuhan, China. And when a nonprofit called EcoHealth Alliance lost a grant because it was planning to conduct risky research into bat viruses with the Wuhan Institute of Virology — research that, if conducted with lax safety standards, could have resulted in a dangerous pathogen leaking out into the world — no fewer than 77 Nobel laureates and 31 scientific societies lined up to defend the organization. So, the Wuhan research was totally safe and the pandemic was definitely caused by natural transmission: It certainly seemed like consensus.We have since learned, however, that to promote the appearance of consensus, some officials and scientists hid or understated crucial facts, misled at least one reporter, orchestrated campaigns of supposedly independent voices and even compared notes about how to hide their communications in order to keep the public from hearing the whole story. And as for that Wuhan laboratory’s research, the details that have since emerged show that safety precautions may have been terrifyingly lax.Five years after the onset of the Covid pandemic, it’s tempting to think of all that as ancient history. We learned our lesson about lab safety — and about the need to be straight with the public — and now we can move on to new crises, like measles or the evolving bird flu, right?Wrong. If anyone needs convincing that the next pandemic is only an accident away, check out a recent paper in Cell, a prestigious scientific journal. Researchers, many of whom work or have worked at the Wuhan Institute of Virology (yes, the same institution), describe taking samples of viruses found in bats (yes, the same animal) and experimenting to see if they could infect human cells and pose a pandemic risk.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?

    A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.It’s easy to make a medical case for blockbuster weight loss drugs like Wegovy and Zepbound, which have been shown to prevent heart attacks and strokes and save lives.But for the employers and government programs being asked to pay for the medications, the financial case for them is less clear. Are the drugs’ benefits worth their enormous cost?The answer right now is no, according to a new study published on Friday in the journal JAMA Health Forum, by researchers at the University of Chicago.To be considered cost effective by a common measure used by health economists, the price of Novo Nordisk’s Wegovy would need to be cut by over 80 percent, to $127 per month, the researchers concluded. And Eli Lilly’s Zepbound would be cost effective only if its price fell by nearly a third, to $361 per month. (Zepbound warranted a higher price, the researchers said, because it produced greater benefits in clinical trials.)“There’s no doubt that the drugs are demonstrating tremendous health benefits,” said David Kim, a health economist at the University of Chicago and the senior author of the study, which was funded by government grants. “The problem is the price is too high.”There’s widespread hope that the drugs will effectively pay for themselves in the long run, by making patients healthier and preventing expensive medical bills. It’s not clear yet whether that will turn out to be true.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    L.A.’s Clear Skies Conceal a ‘Toxic Soup’

    On a Sunday in February, a white Ford van zigzagged through the fire-ravaged neighborhood of Altadena, Calif. Ash piles lined front yards. Charred washing machines sat on bare concrete foundations.“I can’t imagine coming back to this,” said Albert Kyi, a graduate student researcher at the University of Texas at Austin, briefly looking up from his laptop and out the van’s window.He and his colleagues, however, were there to help people learn whether it was safe to do just that. A mast poking out from the van’s roof was sending readings on hundreds of compounds in the air to the laptop. This laboratory on wheels was so sensitive, Mr. Kyi said, that it could detect the chemicals produced by someone peeling an orange outside.The data the team was gathering was part of a newly launched study tracking the health impacts of the Los Angeles wildfires over the next decade. By traversing the 38,000 acres that encompass the two burn zones in Altadena and the Pacific Palisades along with the surrounding region, the researchers hope to fill gaps in the data on air, soil and water quality. Already, they have found cause for concern.More than 16,000 homes and buildings were destroyed, and another 2,000 were damaged during the recent fires. So far, there is only limited information for the tens of thousands of residents returning home to the affected areas about whether or when it might be safe to grow vegetables in their backyards, swim in their pools or go for a morning run, especially as rebuilding efforts stir up potentially toxic ash.On weather apps, the Air Quality Index that day indicated that the air above Altadena posed little risk.The sky was blue, and there was even a cyclist on the streets.But the van’s readings told a different story.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Lila Sciences Uses A.I. to Turbocharge Scientific Discovery

    Across the spectrum of uses for artificial intelligence, one stands out.The big, inspiring A.I. opportunity on the horizon, experts agree, lies in accelerating and transforming scientific discovery and development. Fed by vast troves of scientific data, A.I. promises to generate new drugs to combat disease, new agriculture to feed the world’s population and new materials to unlock green energy — all in a tiny fraction of the time of traditional research.Technology companies like Microsoft and Google are making A.I. tools for science and collaborating with partners in fields like drug discovery. And the Nobel Prize in Chemistry last year went to scientists using A.I. to predict and create proteins.This month, Lila Sciences went public with its own ambitions to revolutionize science through A.I. The start-up, which is based in Cambridge, Mass., had worked in secret for two years “to build scientific superintelligence to solve humankind’s greatest challenges.”Relying on an experienced team of scientists and $200 million in initial funding, Lila has been developing an A.I. program trained on published and experimental data, as well as the scientific process and reasoning. The start-up then lets that A.I. software run experiments in automated, physical labs with a few scientists to assist.Already, in projects demonstrating the technology, Lila’s A.I. has generated novel antibodies to fight disease and developed new materials for capturing carbon from the atmosphere. Lila turned those experiments into physical results in its lab within months, a process that most likely would take years with conventional research.Catie Ramnarine, a research assistant at the Lila Sciences lab in Cambridge, Mass., where artificial intelligence is rapidly accelerating the scientific process. We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More